Newamsterdam Pharma Company N V (NAMSW)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Newamsterdam Pharma Company N V Stock (NAMSW) Company Profile

Newamsterdam Pharma Company N V

Healthcare (1130)

Biotechnology (633)

31 35 206 2971

Gooimeer 2-35, Naarden

Nächster Verdiensttermin

Neueste SEC-Einreichungen

NAMSW's Discussions on Twitter

Vergleichen Sie NAMSW mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
NAMSW Newamsterdam Pharma Company N V	19.63	0	0	0	0	0.00
VRTX Vertex Pharmaceuticals Inc	459.90	117.45B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	778.21	82.50B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	401.28	52.92B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	843.20	52.02B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	176.77	37.94B	447.02M	-1.18B	-906.14M	-6.1812

Newamsterdam Pharma Company N V Aktie (NAMSW) Neueste Nachrichten

Finanzdaten der Newamsterdam Pharma Company N V-Aktie (NAMSW)

Es liegen keine Finanzdaten für Newamsterdam Pharma Company N V (NAMSW) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Newamsterdam Pharma Company N V (NAMSW)

Newamsterdam Pharma Company N V Stock (NAMSW) Company Profile

Vergleichen Sie NAMSW mit anderen Aktien

Newamsterdam Pharma Company N V Aktie (NAMSW) Neueste Nachrichten

How (NAMSW) Movements Inform Risk Allocation Models - Stock Traders Daily

Is NewAmsterdam Pharma Company NV Equity Warrant a good long term investmentUtilities Sector Analysis & Identify Ideal Buy Points With Precision - earlytimes.in

EBITDA per share of NewAmsterdam Pharma Company N.V. – MUN:KH6 - TradingView — Track All Markets

Operating cash flow per share of NewAmsterdam Pharma Company N.V. – SWB:KH6 - TradingView — Track All Markets

(NAMS) Volatility Zones as Tactical Triggers - Stock Traders Daily

Can NewAmsterdam Pharma Company N.V. Equity Warrant stock outperform in 2025 bull marketMarket Growth Report & Short-Term Trading Alerts - Улправда

Aug Retail: Can NewAmsterdam Pharma Company NV stock deliver strong Q4 earningsTrade Exit Report & Weekly Top Performers Watchlists - moha.gov.vn

How NewAmsterdam Pharma Company N.V. Equity Warrant stock trades before earningsWeekly Investment Summary & Verified Swing Trading Watchlist - Улправда

Will NewAmsterdam Pharma Company N.V. stock deliver strong dividend growthEarnings Risk Summary & Detailed Earnings Play Strategies - Улправда

Can NewAmsterdam Pharma Company N.V. stock beat market expectations this quarterQuarterly Profit Report & Real-Time Volume Spike Alerts - Улправда

Aug Selloffs: Can NewAmsterdam Pharma Company N.V. stock beat market expectations this quarterMarket Trend Review & Weekly Watchlist for Consistent Profits - Улправда

Is NewAmsterdam Pharma Company N.V. stock in correction or buying zone2025 Sector Review & Reliable Breakout Forecasts - Улправда

Is NewAmsterdam Pharma Company N.V. stock undervalued vs historical averagesJuly 2025 Technicals & Daily Stock Trend Reports - DonanımHaber

Why NewAmsterdam Pharma Company N.V. Equity Warrant stock attracts high net worth investorsMarket Performance Recap & Expert Curated Trade Ideas - DonanımHaber

Will NewAmsterdam Pharma Company N.V. stock outperform tech sector in 20252025 Earnings Surprises & Community Trade Idea Sharing - DonanımHaber

Why NewAmsterdam Pharma Company N.V. stock attracts global investorsOptions Play & Real-Time Sentiment Analysis - DonanımHaber

How NewAmsterdam Pharma Company N.V. Equity Warrant stock reacts to global recession fearsJuly 2025 Macro Moves & Scalable Portfolio Growth Methods - DonanımHaber

Is NewAmsterdam Pharma Company N.V. stock positioned for long term growthJuly 2025 Short Interest & High Return Trade Guides - Улправда

Will NewAmsterdam Pharma Company N.V. stock beat EPS estimatesPortfolio Gains Report & Real-Time Stock Entry Alerts - ulpravda.ru

NewAmsterdam Pharma (NASDAQ:NAMS) Given New $50.00 Price Target at Stifel Nicolaus - Defense World

NewAmsterdam Pharma (NASDAQ:NAMS) Stock Price Expected to Rise, Stifel Nicolaus Analyst Says - MarketBeat

Understanding Momentum Shifts in (NAMSW) - Stock Traders Daily

Is It Too Late To Consider NewAmsterdam Pharma After Its Strong 2025 Share Price Rally? - Yahoo Finance

Frazier Life Sciences Management L.P. Has $300.75 Million Stock Position in NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat

NewAmsterdam Pharma Company N.V. $NAMS Holdings Lifted by Maverick Capital Ltd. - MarketBeat

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Price-Driven Insight from (NAMS) for Rule-Based Strategy - Stock Traders Daily

It is Poised to be a Bull Market for NewAmsterdam Pharma Company NV (NAMS) - setenews.com

Stempoint Capital LP Boosts Stake in NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat

SCYNEXIS (NASDAQ:SCYX) versus NewAmsterdam Pharma (NASDAQ:NAMS) Head to Head Analysis - Defense World

NewAmsterdam Pharma Company N.V. $NAMS Shares Sold by Affinity Asset Advisors LLC - Defense World

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

NAMS Analyst Forecasts - Quiver Quantitative

NewAmsterdam Pharma Company Grants Inducement Share Options to New Hires - Quiver Quantitative

Saturn V Capital Management LP Buys 104,342 Shares of NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat

Will NewAmsterdam Pharma Company N.V. Equity Warrant stock gain from lower inflationMarket Growth Review & Free Technical Pattern Based Buy Signals - Newser

Is NewAmsterdam Pharma Company N.V. (KH6) stock attractive post correction2025 Volatility Report & Weekly High Conviction Trade Ideas - Newser

Will NewAmsterdam Pharma Company N.V. Equity Warrant stock see PE expansionJuly 2025 Macro Moves & Entry and Exit Point Strategies - Newser

NewAmsterdam Pharma (NASDAQ:NAMS) Shares Gap DownHere's Why - MarketBeat

NAMS: PREVAIL CVOT remains on track for 2026, with regulatory and commercial momentum building - TradingView

JPMorgan Chase & Co. Increases Stock Position in NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat

How NewAmsterdam Pharma Company N.V. (KH6) stock trades after earningsWeekly Trade Analysis & Consistent Profit Trade Alerts - Newser

Transcript : NewAmsterdam Pharma Company N.V. Presents at Citi Annual Global Healthcare Conference 2025, Dec-03-2025 03 - marketscreener.com

A better buy-in window may exist right now for NewAmsterdam Pharma Company NV (NAMS) - Setenews

Is NewAmsterdam Pharma Company N.V. (KH6) stock a defensive play amid uncertaintyEarnings Summary Report & Reliable Intraday Trade Alerts - Newser

Will NewAmsterdam Pharma Company N.V. stock benefit from commodity pricesGap Down & Smart Money Movement Alerts - Newser

Will NewAmsterdam Pharma Company N.V. (KH6) stock announce special dividendWeekly Earnings Recap & Technical Entry and Exit Alerts - Newser

Is NewAmsterdam Pharma Company N.V. Equity Warrant stock a dividend growth opportunity2025 Risk Factors & AI Forecasted Entry and Exit Points - Newser

Why NewAmsterdam Pharma Company N.V. (KH6) stock signals breakout potential2025 Stock Rankings & Low Drawdown Momentum Ideas - Newser

Owner Bain Capital Life Sciences Fund II LP Files To Sell 267,429 Of NewAmsterdam Pharma Co NV [NAMS] - TradingView — Track All Markets

Franklin Resources Inc. Purchases 78,300 Shares of NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat

Finanzdaten der Newamsterdam Pharma Company N V-Aktie (NAMSW)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie NAMSW